The key gene alterations associated with lung cancer recurrence include PD-L1 mutations that enable the tumor cell to evade immune surveillance [53], and CD8 and CD44 mutations that play roles in cell adhesion and migration [55,56]. Here, CD44 is linked to lung cancer.